EZH2i unlocks PDAC immune surveillance
Authors:
- 27 June 2023
- journal article
- editorial
- Published by Springer Nature in Nature Cancer
- Vol. 4 (6) , 781-783
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Immunomodulation by targeted anticancer agentsCancer Cell, 2021
- The functions of EZH2 in immune cells: Principles for novel immunotherapiesJournal of Leukocyte Biology, 2020
- Challenges and Opportunities for Pancreatic Cancer ImmunotherapyCancer Cell, 2020
- A guide to cancer immunotherapy: from T cell basic science to clinical practiceNature Reviews Immunology, 2020
- Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas CancerCell, 2020
- Molecular Mechanisms Directing PRC2 Recruitment and H3K27 MethylationMolecular Cell, 2019
- Epigenetic therapy in immune-oncologyNature Reviews Cancer, 2019
- NK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combinationScience, 2018
- Origin and function of myofibroblasts in kidney fibrosisNature Medicine, 2013
- The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cellsGenes & Development, 2007